Keyword: Sanford Burnham Prebys Medical Discovery Institute
Two research groups have uncovered clues to immuno-oncology drug resistance, offering insight that could lead to new treatment strategies.
Blocking a pathway that causes healing cells to turn bad could offer a new way to treat neurological disorders.
A Stanford team aimed at host cells to fight flaviviruses, while Harvard scientists examined the longevity of Zika vaccines.
Biotech news over the last week included a reversible sealant to shore up eye injuries and a promising gene therapy for the immune disorder known as "bubble boy" disease.
The past week brought new insights into how beige fat cells burn glucose, a particular protein foretells Alzheimer's and bacteria evade antibiotics.
Two sets of researchers announced progress this week advancing research aimed at targeting addiction centers in the brain.
Protein signaling in adipose tissue could play a broad role in preventing obesity and diabetes, Sanford Burnham researchers have found.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a nanosystem that uses "quantum dots" to improve the imaging of human tumors in mice.
Scientists at Sanford Burnham Prebys have identified a compound that prevents Zika infection by blocking the virus’ protease function.
Scientists at Sanford Burnham have identified the mechanism that causes muscle cells to stop regenerating, which could lead to methods for slowing age-related muscle decline.